Hyperlipidemia in continuous ambulatory peritoneal dialysis patients.
Hyperlipidemia is frequently seen in continuous ambulatory peritoneal dialysis patients. The cause of abnormal lipid profile in these patients is multifactorial. In both short and long term studies, abnormal levels of total cholesterol, triglycerides, and, HDL cholesterol were observed. In short term studies, both lovastatin and gemfibrozil were shown to favorably alter the lipid profile.
Lal
S M
SM
Department of Internal Medicine, University of Missouri-Columbia 65212.
D002784:Cholesterol / Q000097:blood; D015248:Gemfibrozil / Q000627:therapeutic use; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy / Q000209:etiology*; D008077:Lipoproteins, LDL / Q000097:blood; D008148:Lovastatin / Q000627:therapeutic use; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects*; D014280:Triglycerides / Q000097:blood
D008077:Lipoproteins, LDL; D014280:Triglycerides; D002784:Cholesterol; D008148:Lovastatin; D015248:Gemfibrozil